Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
2,4-Dichloro-6,7-dimethoxyquinazoline (Doxazosin EP Impurity E) is an intermediate in the preparation of potential inhibitors of epidermal growth factor receptor kinases. An intermediate in the preparation of Terazosin (T105000).